VentriPoint Diagnostics Ltd. ("VentriPoint" or the "Corporation") (TSX VENTURE:VPT) is pleased to announce that the manuscript entitled, "Accuracy of Knowledge Based Reconstruction (KBR) for Measurement of Right Ventricular Volume and Function in Patients with Tetralogy of Fallot" has been accepted for publication in the American Journal of Cardiology. The study will be published in the journal's April, 2010 issue.
This study demonstrated the accuracy and reproducibility of the KBR method which enables physicians to monitor their patients' hearts from ultrasound or magnetic resonance images. The results of the study were presented at the Scientific Sessions of the American Heart Association in November, 2008 by the lead author, Dr. Florence Sheehan, a cardiologist and professor at the University of Washington. She led a multinational team of investigators in collecting and analyzing patient data for the study.
The KBR method was successfully applied for patients with the most common type of congenital heart disease (CHD) causing a "blue baby" at birth. Studies are in progress at VentriPoint to validate KBR for the other types of CHD. The investigative team has enlarged to now include sites in Canada, the UK, the Netherlands, and Switzerland in addition to the U.S., indicating the intense clinical need everywhere for VentriPoint's service.